Quince Therapeutics, Inc. (QNCX)
NASDAQ·Healthcare·Biotechnology
$22.00
+13.58%
Mkt Cap $5.85M
No analyst coverage available
We don't have analyst ratings or price target data for Quince Therapeutics, Inc. yet. Coverage gaps are common for sub-$1B market caps and recently-listed names.